...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma
【24h】

Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma

机译:低剂量的人SCFV衍生的BCMA靶向的CAR-T细胞在复发/难治性多发性骨髓瘤患者中达到了快速的反应和高完全缓解

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
  • 作者单位

    Wenzhou Med Univ Affiliated Hosp 1 Wenzhou Peoples R China;

    Zhejiang Univ Sch Med Affiliated Hosp 1 Hangzhou Zhejiang Peoples R China;

    Shanghai Jiao Tong Univ Xinhua Hosp Sch Med Shanghai Peoples R China;

    Zhejiang Univ Sch Med Affiliated Hosp 1 Hangzhou Zhejiang Peoples R China;

    Shanghai Jiao Tong Univ Xinhua Hosp Sch Med Shanghai Peoples R China;

    CARsgen Therapeut Co Ltd Shanghai Peoples R China;

    CARsgen Therapeut Co Ltd Shanghai Peoples R China;

    CARsgen Therapeut Co Ltd Shanghai Peoples R China;

    CARsgen Therapeut Co Ltd Shanghai Peoples R China;

    Wenzhou Med Univ Affiliated Hosp 1 Wenzhou Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 血液及淋巴系疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号